BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24577364)

  • 21. Short-term change in kidney function and risk of end-stage renal disease.
    Turin TC; Coresh J; Tonelli M; Stevens PE; de Jong PE; Farmer CK; Matsushita K; Hemmelgarn BR
    Nephrol Dial Transplant; 2012 Oct; 27(10):3835-43. PubMed ID: 22764191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteopontin in antineutrophil cytoplasmic autoantibody-associated vasculitis: relation to disease activity, organ manifestation and immunosuppressive therapy.
    Lorenzen J; Lovric S; Krämer R; Haller H; Haubitz M
    Ann Rheum Dis; 2010 Jun; 69(6):1169-71. PubMed ID: 20424002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal function and ear, nose, throat involvement in anti-neutrophil cytoplasmic antibody-associated vasculitis: prospective data from the European Vasculitis Society clinical trials.
    Rahmattulla C; de Lind van Wijngaarden RA; Berden AE; Hauer HA; Floßmann O; Jayne DR; Gaskin G; Rasmussen N; Noël LH; Ferrario F; Waldherr R; Wolterbeek R; Göçeroğlu A; Pusey CD; Hagen EC; Bruijn JA; Bajema IM;
    Rheumatology (Oxford); 2015 May; 54(5):899-907. PubMed ID: 25342376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics and prognostic risk factors of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV).
    Chen Z; Lin L; Yang W; Chen N; Lin Y
    Int Immunopharmacol; 2020 Oct; 87():106819. PubMed ID: 32717565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and pathological study on patients with primary antineutrophil cytoplasmic autoantibody-associated vasculitis with renal immune complex deposition.
    Li X; Zhang W; Yu HJ; Pan XX; Shen PY; Ren H; Wang WM; Chen N
    J Clin Rheumatol; 2015 Jan; 21(1):3-9. PubMed ID: 25539426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical, serological and histological determinants of patient and renal outcome in ANCA-associated vasculitis with renal involvement: an analysis from a referral centre.
    Crnogorac M; Horvatic I; Toric L; Galesic Ljubanovic D; Tisljar M; Galesic K
    Int Urol Nephrol; 2017 Aug; 49(8):1419-1431. PubMed ID: 28646482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a matched-pair cohort study.
    Morgan MD; Turnbull J; Selamet U; Kaur-Hayer M; Nightingale P; Ferro CJ; Savage CO; Harper L
    Arthritis Rheum; 2009 Nov; 60(11):3493-500. PubMed ID: 19877070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzymatic creatinine assays allow estimation of glomerular filtration rate in stages 1 and 2 chronic kidney disease using CKD-EPI equation.
    Kuster N; Cristol JP; Cavalier E; Bargnoux AS; Halimi JM; Froissart M; Piéroni L; Delanaye P;
    Clin Chim Acta; 2014 Jan; 428():89-95. PubMed ID: 24220551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent hematuria in patients with antineutrophil cytoplasmic antibody-associated vasculitis during clinical remission: chronic glomerular lesion or low-grade active renal vasculitis?
    Lv L; Chang DY; Li ZY; Chen M; Hu Z; Zhao MH
    BMC Nephrol; 2017 Dec; 18(1):354. PubMed ID: 29207950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of renal function in the elderly Italians: a physiologic or pathologic process?
    Esposito C; Torreggiani M; Arazzi M; Serpieri N; Scaramuzzi ML; Manini A; Grosjean F; Esposito V; Catucci D; La Porta E; Dal Canton A
    J Gerontol A Biol Sci Med Sci; 2012 Dec; 67(12):1387-93. PubMed ID: 22923431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Predictors of Outcome in Patients with Anti-neutrophil Cytoplasmic Autoantibody-related Renal Vasculitis: Experiences from a Single-center.
    Pu L; Li GS; Zou YR; Zhang P; Wang L
    Chin Med J (Engl); 2017 Apr; 130(8):899-905. PubMed ID: 28397718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urine IgM excretion predicts outcome in ANCA-associated renal vasculitis.
    Bakoush O; Segelmark M; Torffvit O; Ohlsson S; Tencer J
    Nephrol Dial Transplant; 2006 May; 21(5):1263-9. PubMed ID: 16449276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting outcomes after myocardial infarction by using the Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease study equation: results from the Korea Acute Myocardial Infarction Registry.
    Choi JS; Kim CS; Bae EH; Ma SK; Ahn YK; Jeong MH; Kim YJ; Cho MC; Kim CJ; Kim SW;
    Nephrol Dial Transplant; 2012 Oct; 27(10):3868-74. PubMed ID: 22879394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of glomerular filtration rate: does haemoglobin discriminate between ageing and true CKD?
    Ferrari P; Xiao J; Ukich A; Irish A
    Nephrol Dial Transplant; 2009 Jun; 24(6):1828-33. PubMed ID: 19131346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Robotic partial nephrectomy for small renal masses in patients with pre-existing chronic kidney disease.
    Guillotreau J; Yakoubi R; Long JA; Klink J; Autorino R; Hillyer S; Miocinovic R; Rizkala E; Laydner H; Stein RJ; Kaouk JH; Haber GP
    Urology; 2012 Oct; 80(4):845-51. PubMed ID: 23021665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
    Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan.
    Hwang SJ; Lin MY; Chen HC; Hwang SC; Yang WC; Hsu CC; Chiu HC; Mau LW
    Nephrol Dial Transplant; 2008 Oct; 23(10):3192-8. PubMed ID: 18450830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum urea nitrogen, creatinine, and estimators of renal function: mortality in older patients with cardiovascular disease.
    Smith GL; Shlipak MG; Havranek EP; Foody JM; Masoudi FA; Rathore SS; Krumholz HM
    Arch Intern Med; 2006 May; 166(10):1134-42. PubMed ID: 16717177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides.
    Terrier B; Saadoun D; Sène D; Ghillani P; Amoura Z; Deray G; Fautrel B; Piette JC; Cacoub P
    Ann Rheum Dis; 2009 Oct; 68(10):1564-71. PubMed ID: 18957481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Body mass index, coronary artery calcification, and kidney function decline in stage 3 to 5 chronic kidney disease patients.
    Garland JS; Holden RM; Hopman WM; Gill SS; Nolan RL; Morton AR
    J Ren Nutr; 2013 Jan; 23(1):4-11. PubMed ID: 22542819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.